Zhong‐Yi Dong
- Oncology top 1%
- Pulmonary and Respiratory Medicine top 1%
- Molecular Biology top 10%
- Cancer Research top 2%
- Immunology top 5%
- Topics
- Cancer Immunotherapy and Biomarkers (30 papers)Lung Cancer Treatments and Mutations (27 papers)Cancer Genomics and Diagnostics (14 papers)
- Partner nations
- ChinaUnited StatesGermany
In The Last Decade
Zhong‐Yi Dong
67 papers receiving 3.0k citations
Hit Papers
Peers
Comparison fields: 5 of 86
- Oncology 2.0k
- Pulmonary and Respiratory Medicine 1.5k
- Molecular Biology 853
- Cancer Research 722
- Immunology 532
Countries citing papers authored by Zhong‐Yi Dong
This map shows the geographic impact of Zhong‐Yi Dong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhong‐Yi Dong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhong‐Yi Dong more than expected).
Fields of papers citing papers by Zhong‐Yi Dong
This network shows the impact of papers produced by Zhong‐Yi Dong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhong‐Yi Dong. The network helps show where Zhong‐Yi Dong may publish in the future.
Co-authorship network of co-authors of Zhong‐Yi Dong
This figure shows the co-authorship network connecting the top 25 collaborators of Zhong‐Yi Dong. A scholar is included among the top collaborators of Zhong‐Yi Dong based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhong‐Yi Dong. Zhong‐Yi Dong is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 3 | |
| 3 | 0 | |
| 4 | 8 | |
| 5 | 4 | |
| 6 | 35 | |
| 7 | 19 | |
| 8 | 10 | |
| 9 | 233 | |
| 10 | 1 | |
| 11 | 117 | |
| 12 | 2 | |
| 13 | 56 | |
| 14 | 0 | |
| 15 | 101 | |
| 16 | 1 | |
| 17 | 1 | |
| 18 | 0 | |
| 19 | 120 | |
| 20 | Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinomabreakdown → | 741 |
About Zhong‐Yi Dong
Zhong‐Yi Dong is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 73 papers that have together received 3.0k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (30 papers), Lung Cancer Treatments and Mutations (27 papers) and Cancer Genomics and Diagnostics (14 papers). The work is most often cited by research in Oncology (2.0k citations), Cancer Research (722 citations) and Pulmonary and Respiratory Medicine (1.5k citations). Zhong‐Yi Dong has collaborated with scholars based in China, United States and Germany. Frequent co-authors include Yi‐Long Wu, Wen‐Zhao Zhong, Jian Su, Li‐Xu Yan, Zhi Xie, Qing Zhou, Hai‐Yan Tu, Si‐Yang Maggie Liu, Dehua Wu and Li Liu. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and Advanced Functional Materials.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.